CiRa's President Yamanaka (President of Sumitomo Pharma's key research partner) paper from 2011:
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Similarly to the 2000 Yamanaka paper scandal, a user by the name of David Sholto noted similarity within 2 images of the paper of which Yamanaka is listed as an author.
Source:
Show more
Our second report on Sumitomo Chemical and Sumitomo Pharmaceutical (tickers: 4005, 4506) - covering different topics -
expected within the next few days. Stay tuned.
Sumitomo Chemical and Sumitomo Pharmaceutical
(tickers: 4005, 4506): The ¥116 billion Swiss Shuffle
Full Report: Part I
Sumitmo Chemical just reported its earnings for its Fiscal year Q1. How is that so-called "V shaped recovery" going?
- Cash flow from operating activities down YoY
- Free cash flow down, burning even more cash, YoY
This reminds us a lot of Kyndryl, $KD
Show more
Sumitomo Chemical and Sumitomo Pharmaceutical
(tickers: 4005, 4506): The ¥116 billion Swiss Shuffle
Full Report: Part I
Sumitomo Chemical and Sumitomo Pharmaceutical
(tickers: 4005, 4506): The ¥116 billion Swiss Shuffle
Full Report: Part I
